CGON - CG Oncology, Common stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CGON is currently covered by 3 analysts with an average price target of $62.58. This is a potential upside of $35.66 (132.47%) from yesterday's end of day stock price of $26.92.

CG Oncology, Common stock's activity chart (see below) currently has 0 price targets and 14 ratings on display. The stock rating distribution of CGON is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for CGON is $66, Lowest price target is $66, average price target is $70.5.

Most recent stock forecast was given by GREGORY RENZA from RBC on 06-Dec-2024. First documented stock forecast 20-Feb-2024.

Best performing analysts who are covering CGON - CG Oncology, Common stock:

Josh Schimmer Gregory Renza

Currently out of the existing stock ratings of CGON, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$66

$40.3 (156.81%)

$66

8 months 16 days ago
(06-Dec-2024)

0/2 (0%)

$31.41 (90.81%)

Buy

$75

$49.3 (191.83%)

$75

1 years 3 months 16 days ago
(06-May-2024)

0/3 (0%)

$39.9 (113.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CGON (CG Oncology, Common stock) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CGON (CG Oncology, Common stock) with a proven track record?

JOSH SCHIMMER

Which analyst has the current lower performing score on CGON (CG Oncology, Common stock) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on CGON (CG Oncology, Common stock)?

Josh Schimmer works at CANTOR FITZGERALD and has 4 price targets and 4 ratings on CGON

Which analyst is the currently most bullish on CGON (CG Oncology, Common stock)?

Josh Schimmer with highest potential upside - $49.3

Which analyst is the currently most reserved on CGON (CG Oncology, Common stock)?

Gregory Renza with lowest potential downside - $40.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?